Currently, the best peripheral fluid biomarker to distinguish PSP from PD is the light chain of neurofilament (Nf-L) [34,35,36], which however lacks specificity, being elevated also in other neurodegenerative disorders [36,37]. The gene discussed is NEFL; the disease is supranuclear palsy, progressive, 1.